This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of 4,566,195,547 units of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML product, with a ceiling value of $4,782.78. The contract is a firm fixed-price delivery order with an ultimate completion date of October 23, 2024.
DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This specific delivery order for the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML is part of this larger IDC.
Generated 1/22/25, 12:49 AM